IP Library Granted Patent US 9,683,011
Granted Patent B2
US 9,683,011 · App. 14/720,331 · Granted Jun 20, 2017

Controlled cross-linking processing of proteins

Inventors: Gary E. Wnek (Cleveland, OH); Linghui Meng (Cleveland, OH)
Assignee: Case Western Reserve University
C07K1/1075A61L27/22C07K1/107C07K1/36C07K14/78D01F1/10D01F4/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,683,011
App. No.
14/720,331
Granted
Jun 20, 2017
Kind
B2
Abstract

A method of forming a cross-linked protein structures includes preparing a solution of protein dissolved in a benign solvent and forming an intermediate protein structure from the solution. The intermediate protein structure can be cross-linked by providing for a specific ratio of chemical cross-linking agents to form the cross-linked protein structure. The solution can be prepared by adding a cross-linker of N-hydroxysuccinimide (NHS) and 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC) at a ratio of two-to-one of NHS to EDC to alcohol. PBS buffer (20×) can be added to the solution until the volume ratio of PBS buffer (20×) to alcohol is about one-to-one. About 16 percent by weight of protein can be dissolved in the solution. The solution can be electrospun to form an intermediate protein structure. After a period of time, the protein structure can be cross-linked to form the cross-linked protein structure.

Claims (16)

1. A method of forming a protein structure comprising:

forming a solution comprising water, alcohol, salt, collagen, and a cross-linker;

forming a plurality of collagen fibers from the solution; and

after the passage of a period of time, crosslinking at least a portion of the plurality of collagen fibers to form a protein structure.

2. The method of claim 1 , wherein the cross-linker is 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and N-hydroxysuccinimide (NHS).

3. The method of claim 2 , wherein the molar ratio of NHS to EDC is greater than about 1.5:1.

4. The method of claim 3 , wherein a concentration of EDC is about 200 nM and a concentration of NHS is about 400 nM.

5. The method of claim 3 , wherein the salt is a PBS buffer (20×) and a volume ratio of PBS buffer (20×) to alcohol is about 1:1.

6. The method of claim 5 , wherein the collagen is dissolved in the solution.

7. The method of claim 1 , wherein the plurality of collagen fibers are formed by an electrospinning method.

8. The method of claim 7 , wherein the electrospinning method results in the plurality of collagen fibers generally aligned after electrospinning.

9. The method of claim 1 , wherein the protein structure is placed in an environment where the relative humidity is between about 40% and about 60%.

10. The method of claim 1 , wherein the protein structure is immersed in a solution of salt, alcohol and water.

11. The method of claim 2 , wherein the molar ratio of NHS to EDC is about 1:1.

12. The method of claim 6 , wherein the collagen dissolved in the solution is less than about 25 percent by weight.

13. The method of claim 12 , wherein the collagen dissolved in the solution is less than about 16 percent by weight.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jan 29, 2018
From: CASE WESTERN RESERVE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 045175/0473 →
Continuity (5)
Division 13430562 · Mar 26, 2012
Continuation In Part 12571043 · Sep 30, 2009
Provisional Application 61467923 · Mar 25, 2011
Provisional Application 61194685 · Sep 30, 2008
Related Publication 20160046663A1 · Feb 18, 2016